COVID-19 vaccine booster: to boost or not to boost

R Shekhar, I Garg, S Pal, S Kottewar… - Infectious disease …, 2021 - mdpi.com
Developing safe and effective vaccines against severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) at a breakneck speed has been an exceptional human …

COVID-19 vaccine and booster hesitation around the world: A literature review

A Shah, OC Coiado - Frontiers in Medicine, 2023 - frontiersin.org
The development of COVID-19 vaccines has helped limit the extent of the pandemic, which
over the past 2 years has claimed the lived of millions of people. The Moderna and Pfizer …

COVID-19 and resilience of healthcare systems in ten countries

C Arsenault, A Gage, MK Kim, NR Kapoor… - Nature medicine, 2022 - nature.com
Declines in health service use during the Coronavirus Disease 2019 (COVID-19) pandemic
could have important effects on population health. In this study, we used an interrupted time …

Attitudes of medical students toward COVID-19 vaccination: who is willing to receive a third dose of the vaccine?

N Sugawara, N Yasui-Furukori, A Fukushima… - Vaccines, 2021 - mdpi.com
Medical students may come in contact with individuals infected with COVID-19 in their
clinical rotations. A high level of acceptance of vaccination is needed for them to protect their …

The importance of RNA-based vaccines in the fight against COVID-19: an overview

BAS Machado, KVS Hodel, LMS Fonseca… - Vaccines, 2021 - mdpi.com
In recent years, vaccine development using ribonucleic acid (RNA) has become the most
promising and studied approach to produce safe and effective new vaccines, not only for …

The two sides of the covid-19 pandemic

R Kumar, V Srivastava, KN Nand - COVID, 2023 - mdpi.com
On 5 May 2023, the World Health Organization (WHO) officially declared the end of the
coronavirus disease-19 (or COVID-19) pandemic. Even before the official announcement …

An update on the status of vaccine development for SARS-CoV-2 including variants. Practical considerations for COVID-19 special populations

B Kantarcioglu, O Iqbal, J Lewis… - Clinical and Applied …, 2022 - journals.sagepub.com
The progress in the development of various vaccine platforms against SARS-CoV-2 have
been rather remarkable owing to advancement in molecular and biologic sciences. Most of …

Factors associated with not receiving a booster dose of COVID-19 vaccine in Peru

G Bendezu-Quispe, B Caira-Chuquineyra… - Vaccines, 2022 - mdpi.com
To determine the factors associated with not receiving the booster dose for COVID-19 in
Peru, a cross-sectional study by secondary analysis of a University of Maryland and …

Evolving trend change during the COVID-19 pandemic

L Gao, C Zheng, Q Shi, K Xiao, L Wang, Z Liu… - Frontiers in public …, 2022 - frontiersin.org
Coronavirus disease (COVID-19) has caused unimaginable damage to public health and
socio-economic structures worldwide; thus, an epidemiological depiction of the global …

Molecular detection of SARS‐CoV‐2 strains and differentiation of Delta variant strains

V Hamill, L Noll, N Lu, WNT Tsui… - Transboundary and …, 2022 - Wiley Online Library
The Delta variant of SARS‐CoV‐2 has now become the predominant strain in the global
COVID‐19 pandemic. Strain coverage of some detection assays developed during the early …